Pain Hustlers vs. History: How Accurate Is the Opioid Pharma Film?

When Pain Hustlers arrived on Netflix in October 2023, it arrived with impeccable source material. Evan Hughes's 2022 book The Hard Sell is a piece of serious financial crime reporting, and the Insys Therapeutics scandal it documents - a pharmaceutical company that bribed doctors, defrauded insurers, and flooded communities with a fentanyl product far more potent than morphine - is one of the better-documented corporate crimes of the opioid era. Emily Blunt is playing a composite character. The company name has been changed. But the bones of the story are real, and some of the most melodramatic scenes in the film are taken almost directly from trial testimony.

So how much of it is accurate?

Quite a lot of it. But the parts the film gets wrong are instructive, because they reveal the choices any dramatization has to make when it wants audiences to care about a character who was also, objectively, a criminal.

What Hollywood Got RIGHT

The speaker program was exactly as brazen as depicted

The central scheme in Pain Hustlers - paying doctors to attend fake educational dinners, the fee in reality being a kickback for prescriptions - was the exact mechanism at the center of the Insys prosecution. Federal prosecutors demonstrated during the trial that there was a near-perfect correlation between the payments Insys made to individual physicians and the volume of their Subsys prescriptions. Some of the highest-earning "speakers" were paid hundreds of thousands of dollars over a few years. Their prescriptions often went to patients with no cancer diagnosis, which was the only approved use for the drug.

The film's depiction of these events - the cheerful sales rep logging speakers, the steak dinners, the gradual transformation of medical relationships into transactional corruption - reflects testimony given in the Boston federal courthouse almost word for word.

The prior authorization unit was real and meticulously organized

One of the film's most damning sequences shows Liza Drake's colleagues calling insurance companies and impersonating the staff of prescribing physicians to get prior authorization approvals for patients who clearly should not have received a powerful fentanyl spray. This is not a dramatization. Insys ran a dedicated prior authorization unit that did exactly this - submitted false diagnoses, invented supporting clinical details, and coached callers on what to say when insurance nurses pushed back. Several employees in that unit later cooperated with federal prosecutors and described their work in detail.

The RICO prosecution and founder conviction happened

The film correctly shows the Insys founder figure (called Jack Neel, played by Andy Garcia) being prosecuted not simply for business misconduct but under federal racketeering statutes - the same RICO law historically used to dismantle mob organizations. John Kapoor, the real founder, was convicted in May 2019 after a nine-week trial. The prosecution's argument that Insys operated as a criminal enterprise under Kapoor's direction was accepted by the jury. He was sentenced to 66 months in federal prison - more than five years - making him the highest-profile executive convicted in connection with the opioid crisis.

The company culture was genuinely this strange

Emily Blunt's Liza Drake shows up at a company that feels like a pharmaceutical startup crossed with a multilevel marketing operation: aggressive, cash-motivated, light on scientific training, and heavy on theatrical sales techniques. Trial testimony and former employee accounts confirm that Insys's sales culture was genuinely unusual by pharmaceutical industry standards. The company hired reps with backgrounds in entertainment, nightclubs, and unrelated retail sales. Training was short. The compensation system was heavily weighted toward prescription volume.

What Hollywood Got WRONG

Liza Drake does not correspond to a single real person

This is not a flaw so much as a structural choice, but it matters for accuracy. Liza Drake is a composite designed to give the story a sympathetic protagonist whose moral awakening can carry the second and third acts. The real Insys sales operation had no single figure like her. The scheme was run by a VP-level sales team, primarily under Alec Burlakoff, and it was broadly understood across the organization. There was no naive outsider who only gradually realized what she was part of.

Alec Burlakoff was not a charming rogue

Chris Evans plays the Pete Brennan character - the VP who recruits Liza and mentors her into the scheme - as a charismatic but ultimately sympathetic figure who is in over his head. The real Alec Burlakoff, who served as Insys's VP of Sales, pled guilty in 2018 and testified against Kapoor. He was deeply and deliberately complicit in the kickback scheme, not a man who stumbled into crime while chasing a commission. His cooperation with prosecutors, while it reduced his sentence, did not change the record of what he actually organized. Evans's portrayal softens this considerably.

The human cost is largely offscreen

The film's camera stays close to the company's internal drama. The patients who were prescribed a powerful fentanyl product without appropriate clinical justification are largely invisible. The real Insys scandal contributed to a measurable increase in fentanyl overdoses in the communities where the company's top-prescribing physicians practiced. Some of those physicians were themselves later prosecuted. The gap between the film's breezy opening act and the actual body count of the opioid crisis is significant, and Pain Hustlers does not close it.

Jack Neel is more cinematic than the real John Kapoor

Andy Garcia plays Neel as a sleek, withholding figure who operates at arm's length from the daily mechanics of the scheme, suggesting plausible deniability. Federal prosecutors told a different story about Kapoor. Evidence at trial showed he was directly involved in decisions about which physicians should receive speaking fees and at what levels, and that he was aware the program's purpose was to drive prescriptions rather than educate the medical community. The real Kapoor was less enigmatic and more directly hands-on than the film suggests.

Historical Accuracy Score: 7/10

Pain Hustlers is more accurate than most pharmaceutical crime dramas, which is not a high bar. The core mechanisms - the speaker program kickbacks, the prior authorization fraud, the RICO prosecution - are depicted with real fidelity to the public record. Where the film fails is in the choices any dramatization must make to sustain audience sympathy: it creates a composite protagonist who did not exist, softens the most culpable real figures, and keeps the overdose deaths tastefully offscreen.

What it gets most right: the structural mechanics of the Insys bribery scheme and the scope of the federal prosecution.

What it gets most wrong: the human consequences of the fraud, which the film acknowledges but does not sit with.

The underlying story - that a pharmaceutical company received regulatory approval for a legitimate cancer-pain drug and then systematically corrupted the medical system to sell it to people who did not need it - is real, documented, and resulted in convictions. The film is a reasonably faithful account of the business, if not of the damage.

What Pain Hustlers captures well is the organizational logic of pharmaceutical crime: how a corruption scheme can be structured as normal business practice, measured in spreadsheets, rewarded in bonuses, and prosecuted as racketeering. The fentanyl crisis was not an accident. It was, in significant part, the result of specific decisions made in specific boardrooms by people who understood exactly what they were doing. The film shows the boardroom. That is enough to make it worth watching.